What is the environmental impact of a medicine — and how can that insight support better decisions?
Answering that question is complex. Pharmaceutical product assessments must navigate fragmented supply chains, limited primary data, sector-specific methodological challenges and growing demand for credible product-level environmental information.
Watch this on-demand webinar to explore what credible and scalable product sustainability assessment looks like in pharma today.
You’ll gain practical insights into:
- Applying PAS 2090 and what the framework means for pharmaceutical LCAs in practice
- Navigating pharma-specific LCA challenges, from complex value chains and data gaps to methodological considerations
- Closing the pharma data gap with more representative primary and secondary data, including insights from Sphera’s Pharma LCA Data Initiative with 200+ new datasets
- Moving from individual LCAs to scale with more consistent approaches to product footprint assessment
- Turning product-level sustainability data into better decisions across strategy, compliance and portfolio management
Watch the recording to hear practical perspectives on the methodology, data and tools helping pharma companies strengthen product sustainability assessments.
Featured speakers
Hear from Sphera experts who bring hands-on experience in pharmaceutical sustainability, product LCA, carbon footprinting, data strategy and scalable assessment approaches.
